Evidence map›Paper›PMID 35164305›Full record

ArticleMolecules (Basel, Switzerland)2022

Gelatin Coating for the Improvement of Stability and Cell Uptake of Hydrophobic Drug-Containing Liposomes.

Gantumur Battogtokh, Yechan Joo, Sharif Md Abuzar, Heejun Park, Sung-Joo Hwang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Biocompatible gelatin-coated ferrite nanoparticles: A magnetic approach to advanced drug delivery.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Gantumur BattogtokhCollege of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Incheon 21983, Korea.
Yechan JooCollege of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Incheon 21983, Korea.ORCID 0000-0003-2877-9442
Sharif Md AbuzarCollege of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Incheon 21983, Korea.ORCID 0000-0002-9622-5436
Heejun ParkCollege of Pharmacy, Duksung Women's University, 33 Samyangro 144-gil, Seoul 01369, Korea.
Sung-Joo HwangCollege of Pharmacy, Yonsei University, 85 Songdogwahak-ro, Incheon 21983, Korea.ORCID 0000-0001-6521-3822
Yonsei University · KRDuksung Women's University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMost therapeutic agents have limitations owing to low selectivity and poor solubility, resulting in post-treatment side effects. Therefore, there is a need to improve solubility and develop new formulations to deliver therapeutic agents specifically to the target site. Gelatin is a natural protein that is composed of several amino acids. Previous studies revealed that gelatin contains arginyl-glycyl-aspartic acid (RGD) sequences that become ligands for the integrin receptors expressed on cancer cells. Thus, in this study, we aimed to increase the efficiency of drug delivery into cancer cells by coating drug-encapsulating liposomes with gelatin (gelatin-coated liposomes, GCLs).

methodsLiposomes were coated with gelatin using electrostatic interaction and covalent bonding. GCLs were compared with PEGylated liposomes in terms of their size, zeta potential, encapsulation efficiency, stability, dissolution profile, and cell uptake. Results

conclusionsGCLs can be a novel and promising carrier system for targeted anticancer agent delivery. GCLs, which exhibited various characteristics depending on the coating degree, could be utilized in various ways in future studies.

Indexed as

Antineoplastic AgentsDrug LiberationGelatinHeLa CellsHumansLiposomesPolyethylene GlycolsSolubilityAntineoplastic AgentsGelatinLiposomesPolyethylene Glycolslipid nanoparticlepaclitaxelprotein coatingRGD targetingrhodamine B

Identifiers

PMID35164305
PMCPMC8838450
OpenAlexW4210440897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.